TY - JOUR
T1 - Project Transform
T2 - engaging patient advocates to share their perspectives on improving research, treatment and policy
AU - Bridges, John F.P.
AU - Janssen, Ellen M.
AU - Ferris, Andrea
AU - Dy, Sydney M.
N1 - Funding Information:
The authors sincerely thank LUNGevity and the members of the Patient Action Committee (PAC) for their participation, engagement and valuable contributions to Project Transform.
Publisher Copyright:
© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2018/10/3
Y1 - 2018/10/3
N2 - Objective: Incorporating the patient perspective into lung cancer research, policy and treatment is becoming increasingly recognized as important. This project sought to create an engagement partnership with lung cancer patient advocates and to explore their views on transforming lung cancer healthcare systems, treatment and policy to be more patient centered. Methods: A patient action committee (PAC) of patient advocates living with lung cancer was engaged through group meetings, in-person and phone interviews, and email correspondence. Group meetings (two 1 hour meetings, one 3 hour meeting) served to discuss engagement strategies and project goals, while individual interviews (n = 19) (30–75 minutes) provided in-depth exploration of individuals’ perspectives. Meetings and interviews were recorded to identify priorities for addressing issues within lung cancer research, treatment and policy. PAC members corroborated the results through email and in-person meetings. Results: PAC members identified three general objectives: (i) for healthcare systems, increasing access to care through accessible, coordinated and affordable care, (ii) for treatment, addressing patient needs in treatment and research through patient education, shared decisions and clinical trials, and (iii) for policy, shining a light on lung cancer through screening policies, public awareness and research funding. Conclusion: Patient advocates expressed their views that lung cancer is a neglected disease that is not highly prioritized in healthcare systems, treatment approaches and public perceptions. This project represents an integral step in developing an ongoing partnership between researchers and these advocates.
AB - Objective: Incorporating the patient perspective into lung cancer research, policy and treatment is becoming increasingly recognized as important. This project sought to create an engagement partnership with lung cancer patient advocates and to explore their views on transforming lung cancer healthcare systems, treatment and policy to be more patient centered. Methods: A patient action committee (PAC) of patient advocates living with lung cancer was engaged through group meetings, in-person and phone interviews, and email correspondence. Group meetings (two 1 hour meetings, one 3 hour meeting) served to discuss engagement strategies and project goals, while individual interviews (n = 19) (30–75 minutes) provided in-depth exploration of individuals’ perspectives. Meetings and interviews were recorded to identify priorities for addressing issues within lung cancer research, treatment and policy. PAC members corroborated the results through email and in-person meetings. Results: PAC members identified three general objectives: (i) for healthcare systems, increasing access to care through accessible, coordinated and affordable care, (ii) for treatment, addressing patient needs in treatment and research through patient education, shared decisions and clinical trials, and (iii) for policy, shining a light on lung cancer through screening policies, public awareness and research funding. Conclusion: Patient advocates expressed their views that lung cancer is a neglected disease that is not highly prioritized in healthcare systems, treatment approaches and public perceptions. This project represents an integral step in developing an ongoing partnership between researchers and these advocates.
KW - Lung cancer
KW - patient engagement
KW - priority setting
KW - qualitative methods
UR - http://www.scopus.com/inward/record.url?scp=85043339384&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85043339384&partnerID=8YFLogxK
U2 - 10.1080/03007995.2018.1440199
DO - 10.1080/03007995.2018.1440199
M3 - Article
C2 - 29429378
AN - SCOPUS:85043339384
SN - 0300-7995
VL - 34
SP - 1755
EP - 1762
JO - Current Medical Research and Opinion
JF - Current Medical Research and Opinion
IS - 10
ER -